Recurrent pleural effusion as a rare manifestation after prolonged PD1 inhibitor (camrelizumab)-based immunotherapy: A case report

por Xie, Xiao-Hong, Shen, Pan-Xiao, Wu, Jian-Hui, Qiu, Gui-Huan, Lin, Xin-Qing, Xie, Zhan-Hong, Qin, Yin-Yin, Zheng, Bin, Liu, Ming, Zhou, Cheng-Zhi
Publicado 2023